Microbix Net Income Applicable To Common Shares from 2010 to 2026

MBX Stock  CAD 0.22  0.01  4.35%   
Microbix Biosystems Net Loss yearly trend continues to be very stable with very little volatility. Net Loss is likely to grow to about -2.5 M this year. Net Loss is the net income that remains after preferred dividends have been deducted, available to common shareholders. View All Fundamentals
 
Net Loss  
First Reported
2016-12-31
Previous Quarter
-1.6 M
Current Value
-1.5 M
Quarterly Volatility
1.9 M
 
Covid
 
Interest Hikes
Check Microbix Biosystems financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Microbix Biosystems' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.1 M, Interest Expense of 560.6 K or Selling General Administrative of 11 M, as well as many indicators such as Price To Sales Ratio of 2.17, Dividend Yield of 1.97 or PTB Ratio of 1.45. Microbix financial statements analysis is a perfect complement when working with Microbix Biosystems Valuation or Volatility modules.
  
This module can also supplement various Microbix Biosystems Technical models . Check out the analysis of Microbix Biosystems Correlation against competitors.

Latest Microbix Biosystems' Net Income Applicable To Common Shares Growth Pattern

Below is the plot of the Net Income Applicable To Common Shares of Microbix Biosystems over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Microbix Biosystems' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Microbix Biosystems' overall financial position and show how it may be relating to other accounts over time.
Net Income Applicable To Common Shares10 Years Trend
Very volatile
   Net Income Applicable To Common Shares   
       Timeline  

Microbix Net Income Applicable To Common Shares Regression Statistics

Arithmetic Mean(902,248)
Coefficient Of Variation(348.73)
Mean Deviation2,411,498
Median168,979
Standard Deviation3,146,399
Sample Variance9.9T
Range12.1M
R-Value(0.08)
Mean Square Error10.5T
R-Squared0.01
Significance0.75
Slope(51,585)
Total Sum of Squares158.4T

Microbix Net Income Applicable To Common Shares History

2026-2.5 M
2025-2.6 M
2024-2.2 M
20233.5 M
2022-39.5 K
20211.8 M
20203.2 M

About Microbix Biosystems Financial Statements

Microbix Biosystems investors utilize fundamental indicators, such as Net Income Applicable To Common Shares, to predict how Microbix Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss-2.6 M-2.5 M

Other Information on Investing in Microbix Stock

Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.